Drugs / SCD0503
last change May 2026 re-read 2 minutes ago

SCD0503

Developed for
type 1 diabetes mellitus
Investigated by
Profil Institute for Metabolic Research GmbH · Sam Chun Dang Pharm. Co. Ltd.

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07634770 May → Oct 2026 expected type 1 diabetes mellitus Sam Chun Dang Pharm. Co. Ltd. Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SCD0503 “The investigational product tested, SCD0503, is still under clinical evaluation and has not yet been approved for your treatment.” NCT07634770
Route Oral “As the investigational product is administered orally and the comparator product is injected under the skin, two placebos are used in this study.” NCT07634770